HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
6th Edition of Euro-Global Conference on Biotechnology and Bioengineering
September 28-30 | Hybrid Event
Protein / Enzyme Engineering
Protein / Enzyme Engineering
(27-1). Protein & Cell
(27-2). Multiple sequence alignment
(27-3). Exon shuffling
(27-4). Screening and selection techniques
(27-5). In vitro homologous recombination
(27-6). In vitro non-homologous recombination methods
(27-7). DNA shuffling
(27-8). Development on Recombinant Protein
(27-9). Improved kinetic properties
(27-10). Elimination of allosteric regulation
(27-11). Enhanced substrate and reaction specificity
(27-12). Increased thermostability
(27-13). Alteration in optimal pH
(27-14). Suitability for use in organic solvents
(27-15). Increased/decreased optimal temperature
(27-16). Enzyme and Microbial Technology
Committee Members
Thomas J Webster
Brown University, United States
Murray Moo Young
University of Waterloo, Canada
Limongi Tania
University of Turin, Italy ECBB 2026 Speakers
K R Aneja
Kurukshetra University, India
Md Monir Hossain
RMIT University, Australia
Tamer Z Salem
Zewail City of Science and Technology, Egypt
Luis Jesus Villarreal Gomez
Universidad Autonoma de Baja California, MexicoSubmit your abstract Today
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States